Hyliion Holdings Corp. (NYSE:HYLN - Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 15,960,000 shares, a growth of 25.3% from the January 31st total of 12,740,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the short-interest ratio is presently 12.6 days. Approximately 13.7% of the company's shares are short sold.
Hyliion Stock Performance
HYLN traded up $0.04 during trading on Friday, reaching $1.48. 1,045,847 shares of the company's stock were exchanged, compared to its average volume of 1,041,631. The company's fifty day moving average price is $2.17 and its 200-day moving average price is $2.42. The firm has a market capitalization of $257.13 million, a PE ratio of -4.00 and a beta of 2.24. Hyliion has a fifty-two week low of $1.21 and a fifty-two week high of $4.10.
Hedge Funds Weigh In On Hyliion
Hedge funds have recently added to or reduced their stakes in the stock. Squarepoint Ops LLC increased its stake in Hyliion by 492.0% in the fourth quarter. Squarepoint Ops LLC now owns 239,009 shares of the company's stock valued at $624,000 after purchasing an additional 198,633 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of Hyliion in the 4th quarter valued at $150,000. Two Sigma Advisers LP increased its position in shares of Hyliion by 58.4% in the 4th quarter. Two Sigma Advisers LP now owns 130,200 shares of the company's stock valued at $340,000 after buying an additional 48,000 shares in the last quarter. ProShare Advisors LLC raised its stake in Hyliion by 47.5% during the 4th quarter. ProShare Advisors LLC now owns 39,287 shares of the company's stock worth $103,000 after buying an additional 12,657 shares during the period. Finally, Jacobs Levy Equity Management Inc. lifted its holdings in Hyliion by 222.3% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 458,051 shares of the company's stock worth $1,196,000 after acquiring an additional 315,921 shares in the last quarter. Institutional investors and hedge funds own 22.81% of the company's stock.
Hyliion Company Profile
(
Get Free Report)
Read More
Before you consider Hyliion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyliion wasn't on the list.
While Hyliion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
